Immune response and viscosity of haemorrhagic septicaemia oil adjuvant vaccine at different water-oil proportion
260 / 63
Keywords:
Haemorrhagic septicaemia, Oil adjuvant vaccine, Pasteurella multocida, ViscosityAbstract
The Office International des epizooties (OIE) and Food and Agriculture Organisation (FAO) recommends the formulation of oil adjuvant vaccine (OAV) against haemorrhagic septicaemia (HS) with water-in-oil ratio of 50: 50. In present study, 3 different OAV were formulated with water-in-oil ratios; 60: 40 (OAV60), 50: 50 (OAV50) and 40: 60 (OAV40). The immune response study was carried out in mouse model for 45 days. Viscosity of the 3 OAV formulations; OAV60, OAV50 and OAV40 were 426.77 centi poise (cP), 222.40 cP and 128.50 cP respectively. Thus, new formulated vaccine, OAV40, having 10 % less aqueous phase recorded 42% low viscosity compared to standard existing vaccine, OAV50. The immune response was quick in higher aqueous phase vaccine OAV60, which showed significant rise in anti Pasteurella multocida specific Log10 ELISA titer on 14th days post-immunization (DPI) and peak titer on 21st DPI. But vaccine with higher oil phase, such as OAV50 and OAV40, had late but significantly higher and sustained antibody titer up to 45th DPI. All the 3 OAV formulations was protective as it produced 100% protection at 100 LD50 and 60 to 80% protection at 1000 LD50 and 10000 LD50, after challenge on 45th DPI. These results indicated that higher oil proportion in emulsions was effective in reducing viscosity and inducing higher level of sustained antibody response without compromising protection.
Downloads
Downloads
Issue
Section
License
The copyright of the articles published in The Indian Journal of Animal Sciences is vested with the Indian Council of Agricultural Research, which reserves the right to enter into any agreement with any organization in India or abroad, for reprography, photocopying, storage and dissemination of information. The Council has no objection to using the material, provided the information is not being utilized for commercial purposes and wherever the information is being used, proper credit is given to ICAR.